Childrens Tylenol Suspension
NDC Package 50580-245-01
Package Information
Childrens Tylenol (acetaminophen, chlorpheniramine maleate, and dextromethorphan hydrobromide) suspension is this product does not contain directions or complete warnings for adult usedo not give more than directed (see overdose warning)shake well before usingmL = milliliterfind right dose on chart below. This formulation utilizes a suspension delivery system. Marketed by Kenvue Brands Llc, this product is identified by NDC 50580-245 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1086750 - acetaminophen 160 MG / chlorpheniramine maleate 1 MG / dextromethorphan HBr 5 MG in 5 mL Oral Suspension
- RxCUI: 1086750 - acetaminophen 32 MG/ML / chlorpheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Suspension
- RxCUI: 1086750 - acetaminophen 160 MG / chlorpheniramine maleate 1 MG / dextromethorphan hydrobromide 5 MG per 5 ML Oral Suspension
- RxCUI: 1086750 - APAP 32 MG/ML / Chlorpheniramine Maleate 0.2 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML Oral Suspension
Clinical Specifications
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 50580 - Kenvue Brands Llc
- 50580-245 - Childrens Tylenol
- 50580-245-01 - 1 BOTTLE in 1 CARTON / 120 mL in 1 BOTTLE
- 50580-245 - Childrens Tylenol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (50580-245). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50580-245-01 identifies a specific commercial package of 1 bottle in 1 carton / 120 ml in 1 bottle of Childrens Tylenol Cold Plus Cough Plus Runny Nose, a human over the counter drug labeled by Kenvue Brands Llc. This suspension is formulated for oral use and contains acetaminophen; chlorpheniramine maleate; dextromethorphan hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kenvue Brands Llc on June 26, 2017. The current certification is valid through December 31, 2026.
How is this Kenvue Brands Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50580024501. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.